Department of Rheumatology, Sint Maartenskliniek, Nijmegen, the Netherlands; Department of Rheumatic Diseases, Radboud University Medical Center, Nijmegen, the Netherlands.
Department of Rheumatology, Sint Maartenskliniek, Nijmegen, the Netherlands.
Osteoarthritis Cartilage. 2020 Apr;28(4):418-427. doi: 10.1016/j.joca.2020.02.831. Epub 2020 Feb 28.
To evaluate the short-term effects of use of the dr. Bart app, compared to usual care, on the number of secondary health care consultations and clinical outcomes in people with knee/hip OA in the Netherlands.
A randomized controlled design involving participants ≥50 years with self-reported knee and/or hip OA recruited from the community. The number of secondary health care consultations (primary outcome) and secondary outcomes were assessed at baseline, 3 and 6 months via online questionnaires. Data were analyzed using longitudinal mixed models, corrected for baseline values. Due to the design of this study, blinding of participants and researchers was not possible.
In total, 427 eligible participants were allocated to either the dr. Bart group (n = 214) or usual care (n = 213). We found no difference between groups in the number of secondary (i.e., orthopaedic surgeon, rheumatologist, or physician assistant) health care consultations (incidence rate ratio (IRR) 1.20 (95% CI: 0.67; 2.19)). We found positive treatment effects of the dr. Bart app on symptoms (2.6 (95% CI: 0.4; 4.9)), pain (3.5 (95% CI: 0.9; 6.0)), and activities of daily living (2.9 (95% CI: 0.2; 5.6)) on a 0-100 scale, higher score indicating less complaints, but not in any other secondary outcome.
The dr. Bart app did not change the number of secondary health care consultations compared to usual care. However, we found small positive effects (not clinically relevant) on pain, symptoms, and activities of daily living in people with knee/hip OA.
Dutch Trial Register (Trial Number NTR6693/NL6505) (https://www.trialregister.nl/trial/6505).
评估与常规护理相比，荷兰膝关节/髋关节骨关节炎患者使用 dr. Bart 应用程序对就诊次数和临床结局的短期影响。
这是一项涉及社区招募的年龄≥50 岁、自我报告有膝关节和/或髋关节骨关节炎的参与者的随机对照设计。通过在线问卷调查，在基线、3 个月和 6 个月评估就诊次数（主要结局）和次要结局。使用纵向混合模型对数据进行分析，并校正基线值。由于本研究的设计，参与者和研究人员无法设盲。
共有 427 名符合条件的参与者被分配到 dr. Bart 组（n=214）或常规护理组（n=213）。我们发现两组间就诊次数（即骨科医生、风湿病医生或医师助理）无差异（发病率比（IRR）1.20（95%可信区间：0.67；2.19））。我们发现 dr. Bart 应用程序对症状（2.6（95%可信区间：0.4；4.9））、疼痛（3.5（95%可信区间：0.9；6.0））和日常生活活动（2.9（95%可信区间：0.2；5.6））在 0-100 刻度上有积极的治疗效果，得分越高表示抱怨越少，但在其他次要结局上没有。
与常规护理相比，dr. Bart 应用程序并未改变就诊次数。然而，我们发现膝关节/髋关节骨关节炎患者在疼痛、症状和日常生活活动方面有较小的积极影响（无临床意义）。
荷兰试验注册（注册号 NTR6693/NL6505）（https://www.trialregister.nl/trial/6505）。
